Panacea Index Logo

Command Palette

Search for a command to run...

MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial.

Diabetologia
March 1, 2024
Yoriko Heianza et al. (7 authors)
Randomized Controlled TrialJournal ArticleHuman StudyClinical
Study Details

Study Goal

The researchers aimed to determine whether the MTNR1B-rs10830963 genetic variant influences glycemic responses to different carbohydrate quantities and dietary glycemic index (GI) levels.

Results Summary

Carrying the risk G allele of MTNR1B-rs10830963 was associated with greater glycemic responses after consuming a high-carbohydrate/high-GI diet, while reducing GI in high-carbohydrate diets decreased post-OGTT glucose concentrations, particularly in G-allele carriers.

Population

150 participants in a randomized crossover-controlled feeding trial.

Effective Dosage

Not specified

Duration

5 weeks per diet intervention

Interactions

None mentioned

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
high-carbohydrate/high-GI diet
increase
AUC of glucose during 2 h OGTT
risk G allele (CG/GG vs CC genotype) carriers of MTNR1B-rs10830963
β 134.32 [SE 45.69] mmol/l × min
was associated with the largest AUC of glucose during 2 h OGTT
#1
high-carbohydrate/high-GI diet
increase
glucose during 0-60 min
risk G-allele carriers
β 1.26 [0.47] mmol/l
showed greater increment of glucose during 0-60 min
#2
high-carbohydrate/high-GI diet
increase
glucose during 0-90 min
risk G-allele carriers
β 1.10 [0.50] mmol/l
showed greater increment of glucose during 0-90 min
#3
reducing GI levels at high carbohydrate content
decrease
60 min post-OGTT glucose
-
mean -0.67 [95% CI: -1.18, -0.17] mmol/l
decreased 60 min post-OGTT glucose
#4
reducing GI levels at high carbohydrate content
decrease
increment of glucose during 0-60 min
-
mean -1.00 [95% CI: -1.67, -0.33] mmol/l
decreased the increment of glucose during 0-60 min
#5
reducing GI levels at high carbohydrate content
decrease
increment of glucose during 0-90 min
risk G-allele carriers
-
decreased the increment of glucose during 0-90 min
#6
Abstract

AIMS/HYPOTHESIS: A type 2 diabetes-risk-increasing variant, MTNR1B (melatonin receptor 1B) rs10830963, regulates the circadian function and may influence the variability in metabolic responses to dietary carbohydrates. We investigated whether the effects of carbohydrate quantity and dietary glycaemic index (GI) on glycaemic response during OGTTs varied by the risk G allele of MTNR1B-rs10830963. METHODS: This study included participants (n=150) of a randomised crossover-controlled feeding trial of four diets with high/low GI levels and high/low carbohydrate content for 5 weeks. The MTNR1B-rs10830963 (C/G) variant was genotyped. Glucose response during 2 h OGTT was measured at baseline and the end of each diet intervention. RESULTS: Among the four study diets, carrying the risk G allele (CG/GG vs CC genotype) of MTNR1B-rs10830963 was associated with the largest AUC of glucose during 2 h OGTT after consuming a high-carbohydrate/high-GI diet (β 134.32 [SE 45.69] mmol/l × min; p=0.004). The risk G-allele carriers showed greater increment of glucose during 0-60 min (β 1.26 [0.47] mmol/l; p=0.008) or 0-90 min (β 1.10 [0.50] mmol/l; p=0.028) after the high-carbohydrate/high-GI diet intervention, but not after consuming the other three diets. At high carbohydrate content, reducing GI levels decreased 60 min post-OGTT glucose (mean -0.67 [95% CI: -1.18, -0.17] mmol/l) and the increment of glucose during 0-60 min (mean -1.00 [95% CI: -1.67, -0.33] mmol/l) and 0-90 min, particularly in the risk G-allele carriers (p CONCLUSIONS/INTERPRETATION: Our study shows that carrying the risk G allele of MTNR1B-rs10830963 is associated with greater glycaemic responses after consuming a diet with high carbohydrates and high GI levels. Reducing GI in a high-carbohydrate diet may decrease post-OGTT glucose concentrations among the risk G-allele carriers.

Medical Subject Headings (MeSH)
HumansGlycemic IndexGlucoseBlood GlucoseDiabetes Mellitus, Type 2DietGenotypeReceptor, Melatonin, MT2Dietary Carbohydrates
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality85/10
Citation Metrics
Total Citations3
Citations/Year3.0
Research Impact Scores
APT Score0.50
Weight Score2.88
Normalized Score0.67
Related Supplements
MTNR1B genotype and effects of carbohydrate quantity and die... | Panacea Index